Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 12, 2022

SELL
$0.23 - $0.35 $50 - $76
-219 Reduced 12.72%
1,503 $0
Q1 2022

May 16, 2022

SELL
$0.28 - $0.68 $1,456 - $3,536
-5,201 Reduced 75.13%
1,722 $1,000
Q4 2021

Feb 08, 2022

SELL
$0.6 - $1.04 $6,834 - $11,845
-11,390 Reduced 62.2%
6,923 $4,000
Q3 2021

Nov 15, 2021

SELL
$0.99 - $1.38 $57,819 - $80,597
-58,404 Reduced 76.13%
18,313 $19,000
Q2 2021

Sep 13, 2021

BUY
$1.14 - $1.87 $87,457 - $143,460
76,717 New
76,717 $97,000

About TYME TECHNOLOGIES, INC.


  • Ticker TYME
  • Exchange NASDAQ
  • Shares Outstandng 172,207,008
  • Description
  • Tyme Technologies, Inc., a biotechnology company, develops cancer metabolism-based therapies (CMBTs) in the United States. Its lead drug product is SM-88, a CMBT that is in a Phase II/III clinical trial to treat across 15 types of cancer, including pancreatic, prostate, breast, lung, glioma, ovarian, sarcoma, and colon. The company is also devel...
More about TYME
Track This Portfolio

Track Bank Of America Corp Portfolio

Follow Bank Of America Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of America Corp , based on Form 13F filings with the SEC.

News

Stay updated on Bank Of America Corp with notifications on news.